CREATIVE MEDICAL TECHNOLOGY (CELZ) Stock News
NASDAQ:CELZ - Nasdaq - US22529Y4089 - Common Stock - Currency: USD
CELZ Latest News, Press Relases and Analysis
CELZ Stock Earnings: Creative Medical Tech Misses EPS for Q2 2024
CELZ stock results show that Creative Medical Tech missed analyst estimates for earnings per share the second quarter of 2024.
CELZ Stock Earnings: Creative Medical Tech Beats EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Creative Medical Tech (NASDAQ:CELZ) just reported results for the first quarter...
CELZ Stock Earnings: Creative Medical Tech Beats EPS for Q1 2024
CELZ stock results show that Creative Medical Tech beat analyst estimates for earnings per share the first quarter of 2024.
Creative Medical Technology Holdings Provides Corporate Update
Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
Creative Medical Technology Holdings Provides Corporate Update
/PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the week with a breakdown of the biggest pre-market stock movers that investors need to know about for Monday!
Creative Medical nabs FDA nod to run trial for pain therapy
Creative Medical Technology (CELZ) said Tuesday the FDA cleared a Phase 1/2 trial for the company's non-opioid pain therapy StemSpine with AlloStem. Read more here.
SLE, AXLA and ACAX are among pre market gainers (NASDAQ:CELZ)
Creative Medical Technology (CELZ) +17%. Rocket Pharmaceuticals (RCKT) +24% rises as FDA supports accelerated path for gene therapy.Mainz Biomed (MYNZ) +16% Study, Evaluating its...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the latest news for Wednesday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!
Creative Medical Technology regains Nasdaq listing compliance (NASDAQ:CELZ)
Creative Medical Technology (CELZ) said Wednesday that the company regained compliance with the minimum bid price requirement under Nasdaq's listing rule.Press Release.